Search research articles
Contact Us
Filters
Showing results (61-70 of 70) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 70 results.
Cerebrovascular Diseases (Basel, Switzerland)
|
July 23, 2009
T2*-weighted MRI versus oxygen extraction fraction PET in acute stroke
M L Donswijk, P S Jones, J V Guadagno, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
July 20, 2019
Neuroinflammation and Functional Connectivity in Alzheimer's Disease: Interactive Influences on Cognitive Performance
L Passamonti, K A Tsvetanov, P S Jones, et al.
Brain : a Journal of Neurology
|
August 6, 2008
Selective neuronal loss in rescued penumbra relates to initial hypoperfusion
J V Guadagno, P S Jones, F I Aigbirhio, et al.
Journal of Medicinal Chemistry
|
November 12, 1993
Inhibitors of cholesterol biosynthesis. 1. 3,5-Dihydroxy-7-(N-imidazolyl)-6-heptenoates and -heptanoates, a novel series of HMG-CoA reductase inhibitors
C Chan, E J Bailey, C D Hartley, et al.
Nature Communications
|
December 20, 2017
Evidence for causal top-down frontal contributions to predictive processes in speech perception
Thomas E Cope, E Sohoglu, W Sedley, et al.
Cerebrovascular Diseases (Basel, Switzerland)
|
August 24, 2011
Does perfusion computed tomography facilitate clinical decision making for thrombolysis in unselected acute patients with suspected ischaemic stroke?
S Agarwal, P S Jones, J A Alawneh, et al.
Neurology
|
September 13, 2006
How affected is oxygen metabolism in DWI lesions?: A combined acute stroke PET-MR study
J V Guadagno, E A Warburton, P S Jones, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 24, 2001
The identification of alpha-ketoamides as potent inhibitors of hepatitis C virus NS3-4A proteinase
J M Bennett, A D Campbell, A J Campbell, et al.
Antiviral Chemistry & Chemotherapy
|
November 26, 1999
The design and synthesis of potent inhibitors of hepatitis C virus NS3-4A proteinase
M R Attwood, J M Bennett, A D Campbell, et al.
Allergy
|
April 15, 2018
An immunologically relevant rodent model demonstrates safety of therapy using a tumour-specific IgE
D H Josephs, M Nakamura, H J Bax, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 70) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 70 results.
Cerebrovascular Diseases (Basel, Switzerland)
|
July 23, 2009
T2*-weighted MRI versus oxygen extraction fraction PET in acute stroke
M L Donswijk, P S Jones, J V Guadagno, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
July 20, 2019
Neuroinflammation and Functional Connectivity in Alzheimer's Disease: Interactive Influences on Cognitive Performance
L Passamonti, K A Tsvetanov, P S Jones, et al.
Brain : a Journal of Neurology
|
August 6, 2008
Selective neuronal loss in rescued penumbra relates to initial hypoperfusion
J V Guadagno, P S Jones, F I Aigbirhio, et al.
Journal of Medicinal Chemistry
|
November 12, 1993
Inhibitors of cholesterol biosynthesis. 1. 3,5-Dihydroxy-7-(N-imidazolyl)-6-heptenoates and -heptanoates, a novel series of HMG-CoA reductase inhibitors
C Chan, E J Bailey, C D Hartley, et al.
Nature Communications
|
December 20, 2017
Evidence for causal top-down frontal contributions to predictive processes in speech perception
Thomas E Cope, E Sohoglu, W Sedley, et al.
Cerebrovascular Diseases (Basel, Switzerland)
|
August 24, 2011
Does perfusion computed tomography facilitate clinical decision making for thrombolysis in unselected acute patients with suspected ischaemic stroke?
S Agarwal, P S Jones, J A Alawneh, et al.
Neurology
|
September 13, 2006
How affected is oxygen metabolism in DWI lesions?: A combined acute stroke PET-MR study
J V Guadagno, E A Warburton, P S Jones, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 24, 2001
The identification of alpha-ketoamides as potent inhibitors of hepatitis C virus NS3-4A proteinase
J M Bennett, A D Campbell, A J Campbell, et al.
Antiviral Chemistry & Chemotherapy
|
November 26, 1999
The design and synthesis of potent inhibitors of hepatitis C virus NS3-4A proteinase
M R Attwood, J M Bennett, A D Campbell, et al.
Allergy
|
April 15, 2018
An immunologically relevant rodent model demonstrates safety of therapy using a tumour-specific IgE
D H Josephs, M Nakamura, H J Bax, et al.
Page
of 7